ABUS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Arbutus Biopharma Corp (ABUS).


$619.64M Market Cap.

As of 03/27/2025 5:00 PM ET (MRY) • Disclaimer

ABUS Market Cap. (MRY)


ABUS Shares Outstanding (MRY)


ABUS Assets (MRY)


Total Assets

$131.71M

Total Liabilities

$34.34M

Total Investments

$86.29M

ABUS Income (MRY)


Revenue

$6.17M

Net Income

-$69.92M

Operating Expense

$79.86M

ABUS Cash Flow (MRY)


CF Operations

-$64.85M

CF Investing

$22.95M

CF Financing

$52.00M

ABUS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ABUS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$131,707,000 (-8.79%)

$144,401,000 (-26.11%)

$195,419,000 (-4.43%)

$204,485,000 (49.17%)

Assets Current

$127,316,000 (-3.57%)

$132,027,000 (-12.65%)

$151,139,000 (-5.93%)

$160,661,000 (25.81%)

Assets Non-Current

$4,391,000 (-64.51%)

$12,374,000 (-72.06%)

$44,280,000 (1.04%)

$43,824,000 (367.41%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$97,366,000 (-8.16%)

$106,018,000 (-22.53%)

$136,852,000 (-19.23%)

$169,439,000 (66.17%)

Property Plant & Equipment Net

$4,357,000 (-28.46%)

$6,090,000 (-10.63%)

$6,814,000 (-15.62%)

$8,075,000 (-13.47%)

Cash & Equivalents

$36,330,000 (38.22%)

$26,285,000 (-14.59%)

$30,776,000 (-71.84%)

$109,282,000 (109.15%)

Accumulated Other Comprehensive Income

-$48,135,000 (0.59%)

-$48,421,000 (4.09%)

-$50,488,000 (-4.45%)

-$48,335,000 (-0.34%)

Deferred Revenue

$10,434,000 (-11.51%)

$11,791,000 (-47.49%)

$22,455,000 (0%)

$0 (0%)

Total Investments

$86,293,000 (-18.59%)

$106,002,000 (-30.94%)

$153,500,000 (87.83%)

$81,723,000 (15.08%)

Investments Current

$86,293,000 (-13.46%)

$99,718,000 (-14.14%)

$116,137,000 (152.28%)

$46,035,000 (-35.18%)

Investments Non-Current

$0 (0%)

$6,284,000 (-83.18%)

$37,363,000 (4.69%)

$35,688,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$2,409,000 (35.64%)

$1,776,000 (31.36%)

$1,352,000 (50.39%)

$899,000 (-31.48%)

Trade & Non-Trade Payables

$7,564,000 (-26.36%)

$10,271,000 (-35.92%)

$16,029,000 (47.90%)

$10,838,000 (18.44%)

Accumulated Retained Earnings (Deficit)

-$1,346,572,000 (-5.48%)

-$1,276,652,000 (-6.05%)

-$1,203,803,000 (-6.12%)

-$1,134,347,000 (-8.45%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,289,000 (-27.09%)

$1,768,000 (-19.16%)

$2,187,000 (-16.34%)

$2,614,000 (-12.37%)

Debt Current

$483,000 (13.65%)

$425,000 (14.25%)

$372,000 (-2.87%)

$383,000 (-1.79%)

Debt Non-Current

$806,000 (-39.99%)

$1,343,000 (-26.01%)

$1,815,000 (-18.65%)

$2,231,000 (-13.96%)

Total Liabilities

$34,341,000 (-10.53%)

$38,383,000 (-34.46%)

$58,567,000 (67.11%)

$35,046,000 (-0.19%)

Liabilities Current

$15,618,000 (-30.55%)

$22,487,000 (-31.56%)

$32,857,000 (192.82%)

$11,221,000 (17.61%)

Liabilities Non-Current

$18,723,000 (17.78%)

$15,896,000 (-38.17%)

$25,710,000 (7.91%)

$23,825,000 (-6.84%)

ABUS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$6,171,000 (-65.98%)

$18,141,000 (-53.51%)

$39,019,000 (255.11%)

$10,988,000 (58.92%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$22,108,000 (-1.63%)

$22,475,000 (26.02%)

$17,834,000 (4.07%)

$17,136,000 (15.43%)

Research & Development Expense

$54,037,000 (-26.68%)

$73,700,000 (-12.69%)

$84,408,000 (28.86%)

$65,502,000 (32.76%)

Operating Expenses

$79,865,000 (-16.96%)

$96,175,000 (-5.93%)

$102,242,000 (23.72%)

$82,638,000 (28.63%)

Interest Expense

$137,000 (-70.15%)

$459,000 (-73.41%)

$1,726,000 (-39.59%)

$2,857,000 (-28.77%)

Income Tax Expense

$0 (0%)

$0 (0%)

$4,444,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$69,920,000 (4.02%)

-$72,849,000 (-4.89%)

-$69,456,000 (8.91%)

-$76,247,000 (-19.61%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$69,920,000 (4.02%)

-$72,849,000 (-4.89%)

-$69,456,000 (8.91%)

-$76,247,000 (-19.61%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$12,139,000 (0.13%)

Net Income Common Stock

-$69,920,000 (4.02%)

-$72,849,000 (-4.89%)

-$69,456,000 (21.42%)

-$88,386,000 (-16.50%)

Weighted Average Shares

$185,608,874 (11.84%)

$165,960,379 (9.95%)

$150,939,337 (42.07%)

$106,242,452 (40.10%)

Weighted Average Shares Diluted

$185,608,874 (11.84%)

$165,960,379 (9.95%)

$150,939,337 (42.07%)

$106,242,452 (40.10%)

Earning Before Interest & Taxes (EBIT)

-$69,783,000 (3.60%)

-$72,390,000 (-14.39%)

-$63,286,000 (13.77%)

-$73,390,000 (-22.86%)

Gross Profit

$6,171,000 (-65.98%)

$18,141,000 (-53.51%)

$39,019,000 (255.11%)

$10,988,000 (58.92%)

Operating Income

-$73,694,000 (5.56%)

-$78,034,000 (-23.43%)

-$63,223,000 (11.76%)

-$71,650,000 (-24.97%)

ABUS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$22,948,000 (-54.80%)

$50,773,000 (167.75%)

-$74,942,000 (-491.12%)

-$12,678,000 (14.96%)

Net Cash Flow from Financing

$51,996,000 (69.66%)

$30,647,000 (-3.67%)

$31,814,000 (-76.82%)

$137,236,000 (58.20%)

Net Cash Flow from Operations

-$64,850,000 (24.54%)

-$85,936,000 (-143.06%)

-$35,356,000 (47.65%)

-$67,532,000 (-31.28%)

Net Cash Flow / Change in Cash & Cash Equivalents

$10,045,000 (323.67%)

-$4,491,000 (94.28%)

-$78,506,000 (-237.65%)

$57,031,000 (178.85%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$23,130,000 (-55.31%)

$51,761,000 (169.54%)

-$74,430,000 (-527.10%)

-$11,869,000 (2.55%)

Capital Expenditure

-$182,000 (81.58%)

-$988,000 (-92.97%)

-$512,000 (36.71%)

-$809,000 (-253.28%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$51,996,000 (69.66%)

$30,647,000 (-3.67%)

$31,814,000 (-76.82%)

$137,236,000 (58.20%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$49,000 (-296.00%)

$25,000 (213.64%)

-$22,000 (-540.00%)

$5,000 (-91.07%)

Share Based Compensation

$8,986,000 (-3.39%)

$9,301,000 (29.50%)

$7,182,000 (11.80%)

$6,424,000 (4.27%)

Depreciation Amortization & Accretion

$1,380,000 (-1.71%)

$1,404,000 (-1.61%)

$1,427,000 (-18.60%)

$1,753,000 (-11.38%)

ABUS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-1133.00% (-182.12%)

-401.60% (-125.62%)

-178.00% (77.87%)

-804.40% (26.69%)

EBITDA Margin

-1108.50% (-183.29%)

-391.30% (-146.88%)

-158.50% (75.69%)

-652.00% (21.94%)

Return on Average Equity (ROAE)

-63.40% (-9.69%)

-57.80% (-25.11%)

-46.20% (32.75%)

-68.70% (23.50%)

Return on Average Assets (ROAA)

-48.00% (-10.60%)

-43.40% (-33.13%)

-32.60% (39.85%)

-54.20% (16.36%)

Return on Sales (ROS)

-1130.80% (-183.41%)

-399.00% (-145.99%)

-162.20% (75.71%)

-667.90% (22.70%)

Return on Invested Capital (ROIC)

-82.80% (-35.29%)

-61.20% (-34.21%)

-45.60% (48.99%)

-89.40% (13.20%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-8.61 (-51.44%)

-5.68 (-12.18%)

-5.07 (-8.06%)

-4.69 (-32.03%)

Price to Sales Ratio (P/S)

98.35 (330.04%)

22.87 (153.76%)

9.01 (-76.04%)

37.61 (-3.41%)

Price to Book Ratio (P/B)

6.36 (60.95%)

3.95 (48.42%)

2.66 (-14.23%)

3.11 (5.07%)

Debt to Equity Ratio (D/E)

0.35 (-2.49%)

0.36 (-15.42%)

0.43 (106.76%)

0.21 (-39.83%)

Earnings Per Share (EPS)

-0.38 (13.64%)

-0.44 (4.35%)

-0.46 (44.58%)

-0.83 (17.00%)

Sales Per Share (SPS)

0.03 (-69.72%)

0.11 (-57.92%)

0.26 (151.46%)

0.1 (13.19%)

Free Cash Flow Per Share (FCFPS)

-0.35 (33.21%)

-0.52 (-120.17%)

-0.24 (62.99%)

-0.64 (5.58%)

Book Value Per Share (BVPS)

0.53 (-17.84%)

0.64 (-29.55%)

0.91 (-43.13%)

1.59 (18.59%)

Tangible Assets Book Value Per Share (TABVPS)

0.71 (-18.39%)

0.87 (-32.82%)

1.29 (-32.73%)

1.93 (6.47%)

Enterprise Value Over EBIT (EV/EBIT)

-8 (-33.33%)

-6 (-20.00%)

-5 (16.67%)

-6 (-100.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-8.61 (-51.49%)

-5.69 (-2.58%)

-5.54 (11.96%)

-6.3 (-75.13%)

Asset Turnover

0.04 (-61.11%)

0.11 (-40.98%)

0.18 (173.13%)

0.07 (13.56%)

Current Ratio

8.15 (38.85%)

5.87 (27.63%)

4.6 (-67.87%)

14.32 (6.97%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$65,032,000 (25.19%)

-$86,924,000 (-142.34%)

-$35,868,000 (47.52%)

-$68,341,000 (-32.26%)

Enterprise Value (EV)

$589,237,810 (45.99%)

$403,616,118 (17.71%)

$342,879,308 (-23.98%)

$451,055,371 (117.25%)

Earnings Before Tax (EBT)

-$69,920,000 (4.02%)

-$72,849,000 (-12.05%)

-$65,012,000 (14.74%)

-$76,247,000 (-19.61%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$68,403,000 (3.64%)

-$70,986,000 (-14.75%)

-$61,859,000 (13.65%)

-$71,637,000 (-24.03%)

Invested Capital

$81,048,000 (-16.79%)

$97,397,000 (-27.30%)

$133,973,000 (54.71%)

$86,596,000 (10.64%)

Working Capital

$111,698,000 (1.97%)

$109,540,000 (-7.39%)

$118,282,000 (-20.85%)

$149,440,000 (26.47%)

Tangible Asset Value

$131,707,000 (-8.79%)

$144,401,000 (-26.11%)

$195,419,000 (-4.43%)

$204,485,000 (49.17%)

Market Capitalization

$619,637,810 (47.80%)

$419,238,118 (15.00%)

$364,568,308 (-30.72%)

$526,197,371 (74.57%)

Average Equity

$110,336,750 (-12.42%)

$125,990,750 (-16.20%)

$150,339,000 (16.87%)

$128,639,250 (52.20%)

Average Assets

$145,620,250 (-13.20%)

$167,772,250 (-21.23%)

$212,983,250 (30.73%)

$162,924,250 (39.13%)

Invested Capital Average

$84,249,750 (-28.73%)

$118,211,250 (-14.87%)

$138,853,250 (69.13%)

$82,096,250 (41.51%)

Shares

189,491,685 (13.00%)

167,695,247 (7.18%)

156,467,085 (15.67%)

135,269,247 (59.31%)